Edward McSweegan
Alma materBoston College
University of New Hampshire
University of Rhode Island
Scientific career
InstitutionsNaval Medical Research Institute
State Department
National Institute of Allergy and Infectious Diseases
Global Virus Network

Edward McSweegan is an American microbiologist, science writer and fiction author.

Education and early research

McSweegan earned his undergraduate biology degree from Boston College in 1978. He went on to earn two degrees in microbiology, a masters degree from the University of New Hampshire and a Ph.D. from the University of Rhode Island.[1]

In 1984, McSweegan received a resident research associateship from the National Research Council, and he performed postdoctoral research at the Naval Medical Research Institute.[2][1] He published research on the disease-causing mechanisms of the bacteria Campylobacter jejuni and Enterotoxigenic Escherichia coli.[2][3]

Career

From 1986-1988, McSweegan was stationed at the State Department as an American Association for the Advancement of Science diplomacy fellow.[1] At the State Department, he was involved in developing a science and technology pact between the United States and Poland.[4] He helped negotiate additional agreements with Hungary and the former Soviet Union.[1]

In 1988, McSweegan joined the National Institutes of Health's National Institute of Allergy and Infectious Diseases, and eventually became program officer for Lyme disease. [5] McSweegan was among a number of Lyme disease experts who were worried about the influence that an advocacy group was having over the NIH, some politicians, and the general public. The group, called Lyme Disease Foundation, promoted the belief in "chronic Lyme disease" and claimed that it required long-term, expensive, and unproven antibiotic treatments. The group was operated by two accountants, received funding from companies that sold intravenous antibiotics, and made claims that lacked scientific support. It also referred people with indeterminate symptoms to chronic Lyme disease-believing doctors who would diagnose them, even though evidence indicated most did not have Lyme disease.[6]

Beginning in 1995, McSweegan denounced the Lyme Disease Foundation in his personal time and continued to speak out against the group's influence on the NIH.[7][5] The NIH eventually removed him from responsibilities, both related and unrelated to Lyme disease. The media characterized the NIH's actions as retaliation for McSweegan blowing the whistle on NIH mismanagement.[8] In 1997, after noticing that his personal web site characterized the Lyme Disease Foundation as "whacko", the NIH suspended him for two weeks.[6] However, the NIH's own lawyers felt there was no basis for firing him. The Lyme Disease Foundation later sued McSweegan for slander, but lost. McSweegan won a countersuit against them. Through the process, he continued to receive positive job reviews.[7]

The NIH said it reassigned him to a post as director of the U.S.-Indo Vaccine Action Program. McSweegan told The Washington Post in 2003 that he didn't know he was director of that program, and was instead assigned tasks better suited for an intern.[5]

Reports by the Post and CBS News led Senator Chuck Grassley, then the chairman of the Senate Finance Committee, to demand that the NIH give McSweegan work. In a letter to Health and Human Services Secretary Tommy Thompson, Grassley questioned the NIH's uses of taxpayer money, saying it was unacceptable for the NIH to "come rattling a tin cup asking for more money" when it was forcing taxpayers to "pay for full-time novelists."[7] The NIH promised to investigate the allegations.[9]

McSweegan has commented on diverse issues related to infectious disease. In 2004, McSweegan hypothesized that the mysterious "English sweating sickness" may have been an outbreak of anthrax poisoning. He speculated that the victims could have been infected with anthrax spores present in raw wool or infected animal carcasses, and he suggested exhuming the victims for testing.[10] He has also criticized the Centers for Disease Control for investigating Morgellons, a proposed infectious condition whose existence is disputed by current scientific consensus.[11]

Mcsweegan was detailed by the NIH to the Global Virus Network, where he became a program manager.[1] There, he reported on a number of pathogens, including Zika, chikungunya, and Hepatitis C.[12][13][14][15] He worked at the Global Virus Network until 2018.[16]

References

  1. 1 2 3 4 5 "Global Virus Network Staff". Global Virus Network. Archived from the original on 2015-03-15. Retrieved 6 September 2020.
  2. 1 2 McSweegan, E; Walker, R I (1986). "Identification and characterization of two Campylobacter jejuni adhesins for cellular and mucous substrates". Infection and Immunity. 53 (1): 141–148. doi:10.1128/IAI.53.1.141-148.1986. PMC 260088. PMID 2873103.
  3. ↑ Laux, D C; McSweegan, E F; Williams, T J; Wadolkowski, E A; Cohen, P S (1986). "Identification and characterization of mouse small intestine mucosal receptors for Escherichia coli K-12(K88ab)". Infection and Immunity. 52 (1): 18–25. doi:10.1128/IAI.52.1.18-25.1986. PMC 262191. PMID 3007359.
  4. ↑ "U.S., Polish Negotiators Report Progress on New Scientific and Technology Agreement". Los Angeles Times. 28 February 1987. Retrieved 6 September 2020.
  5. 1 2 3 Branigan, Tania (2003-07-04). "NIH Scientist Says He's Paid To Do Nothing". The Washington Post. Retrieved 2007-07-21.
  6. 1 2 Weiss, Rick (1997-04-21). "Lyme Disease Foundation's influence at NIH gets under scientist's skin". Washington Post. Retrieved 29 June 2021.
  7. 1 2 3 Atkisson, Sharyl (2003-06-27). "The Man With No Work". CBSNews.com. CBS News. Retrieved 2007-07-21.
  8. ↑ Shochat, Gil (2003). "Legislation aims to increase whistleblower protections". The News Media & The Law. No. Summer 2003. Retrieved 29 June 2021.
  9. ↑ FederalDaily.com > FederalDaily Top Stories
  10. ↑ Riddle solved? - 17 January 2004 - New Scientist
  11. ↑ "Morgellons | PDF | Delusion | Mental and Behavioural Disorders".
  12. ↑ Aliota, MT; Bassit, L; Bradrick, SS; Cox, B; Garcia-Blanco, MA; Gavegnano, C; Friedrich, TC; Golos, TG; Griffin, DE; Haddow, AD; Kallas, EG; Kitron, U; Lecuit, M; Magnani, DM; Marrs, C; Mercer, N; McSweegan, E; Ng, LFP; O'Connor, DH; Osorio, JE; Ribeiro, GS; Ricciardi, M; Rossi, SL; Saade, G; Schinazi, RF; Schott-Lerner, GO; Shan, C; Shi, PY; Watkins, DI; Vasilakis, N; Weaver, SC (August 2017). "Zika in the Americas, year 2: What have we learned? What gaps remain? A report from the Global Virus Network". Antiviral Research. 144: 223–246. doi:10.1016/j.antiviral.2017.06.001. PMC 5920658. PMID 28595824.
  13. ↑ McSweegan, E; Weaver, SC; Lecuit, M; Frieman, M; Morrison, TE; Hrynkow, S (August 2015). "The Global Virus Network: Challenging chikungunya". Antiviral Research. 120: 147–52. doi:10.1016/j.antiviral.2015.06.003. PMC 4843800. PMID 26071007.
  14. ↑ Akkina, Ramesh; Ellerbrok, Heinz; Hall, William; Hasegawa, Hideki; Kawaguchi, Yasushi; Kleanthous, Harold; McSweegan, Edward; Mercer, Natalia; Romanowski, Victor; Sawa, Hirofumi; Vahlne, Anders (June 2017). "2016 International meeting of the Global Virus Network". Antiviral Research. 142: 21–29. doi:10.1016/j.antiviral.2017.03.005. PMC 7113740. PMID 28315708.
  15. ↑ Mathur, Poonam; Comstock, Emily; McSweegan, Edward; Mercer, Natalia; Kumar, Nongthombam Suraj; Kottilil, Shyamasundaran (October 2017). "A pilot study to expand treatment of chronic hepatitis C in resource-limited settings". Antiviral Research. 146: 184–190. doi:10.1016/j.antiviral.2017.09.007. ISSN 1872-9096. PMID 28927676. Retrieved 12 February 2021.
  16. ↑ McSweegan, Edward (2020). "How conflict and bureaucracy delayed the elimination of yellow fever". Hektoen International Journal. Retrieved 6 September 2020.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.